SAN DIEGO
February 21, 2024 9:00 AM
Newmark[1] announces that life science veteran John Hundley has joined the firm as Executive Managing Director, bolstering life science tenant advisory in Southern California. Hundley is based in the firm’s San Diego, California office and is joined by his team member, Jon Engle.
Hundley brings over 20 years of experience specializing in multi-market life science occupier representation and landlord advisory across San Diego, Los Angeles, the Bay Area, Boston and Seattle. His diverse experience extends beyond pure laboratory space as the technology and life science sectors merge, having represented clients within the office and technology sectors.
“We are excited to welcome John and Jon to Newmark, as we expect the duo’s multi-market focus and expertise to further strengthen our position in the sector,” said Greg May, Executive Vice President and West Region Market Leader for Newmark. “Passionate for his trade, John has become one of San Diego’s leading life science real estate experts. He and Jon harness cutting-edge data analytics, real-time change and marketplace trends to craft proactive real estate solutions that empower the science and technology community.”
Hundley’s most notable transactions include the 170,000-square-foot Torrey Pines campus lease for Pacira Biosciences; the facilitation of a 200,000-square-foot office-to-lab conversion at 1155 Island Avenue in downtown San Diego to Phase 3 Real Estate Partners; and the facilitation of the sale of the Scripps Health headquarters to ARE for the expansion of its mega campus in UTC, Campus Point by Alexandria. Hundley has extensively advised Los Angeles area-based venture capital firm Westlake Village BioPartners, with most recent transactions being on behalf of a portfolio company, Acelyrin Inc., in its office headquarters lease in Los Angeles and lease of lab space in South San Francisco’s Oyster Point.
“I am thrilled to be part of a top-tier firm like Newmark as we enter into a new phase of recovery in the life sciences sector,” said Hundley. “The caliber of people at Newmark, particularly those in the life sciences practice group, as well as the overall commitment to client service and innovation, aligns with our values, ignites and supports our vision for the future and elevates our business to the next level.”
Hundley continued, “It’s all about our clients, and Newmark provides the platform and resources to ensure we deliver the best service possible. We look forward to contributing to the continued success of our clients at Newmark.”
Prior to joining Newmark, Hundley served as an Executive Vice President and Engle as Vice President at Kidder Mathews.
[1] Dba Newmark Knight Frank in California
About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries (“Newmark”), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark’s comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform’s global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. For the year ending December 31, 2022, Newmark generated revenues of approximately $2.7 billion. As of September 30, 2023, Newmark’s company-owned offices, together with its business partners, operate from approximately 170 offices with 7,400 professionals around the world. To learn more, visit nmrk.com or follow @newmark.
Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are “forward-looking statements” that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the effects of the COVID-19 pandemic on the Company’s business, results, financial position, liquidity and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark’s Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
